Pipeline Programs↗
Distinct drugs in development (Preclinical–Phase 3)
Indications↗
Distinct diseases across all programs
Clinical Trials↗
All sponsored trials (all statuses)
Pipeline
By Phase
23 drugs in development
By Therapeutic Area
top 6
R&D Momentum
100/100
Pipeline Velocity
89/100
Trial Completion Rate
74/100
Pipeline Concentration
15/100
Pipeline Freshness
69/100
Strategic Signals
Activity
Last 14 days
Pilot Single Arm Acceptability Study of Mindfulness-Based Stress Reduction for Individuals With Hidradenitis Suppurativa
Kidney Transplant Preemptive Therapy or Prophylaxis (KPoP) for CMV Prevention in D+R- Recipients
Efficacy of Digital Cognitive Behavior Therapy for Insomnia for the Prevention of Perinatal Depression
We Are Together (WAT): Development and Testing of an Intervention to Reduce HIV Related Stigma Among Pregnant and Postpartum Women
Optimizing Attention Bias Modification for Posttraumatic Stress Disorder: An Entirely Remote Study
Connect Cancer Patients to Tobacco Cessation Care by Automated Interactive Outreach
Probiotics to Treat HSIL and Reduce Persistent High Risk HPV Infection in Women and Men Living With HIV
Complex And Simple Appendicitis: REstrictive or Liberal Post-operative Antibiotic eXposure (CASA RELAX) Using Desirability of Outcome Ranking (DOOR) and Response Adjusted for Duration of Antibiotic Risk (RADAR) -A Randomized Controlled Trial
Period Pills for Menstrual Regulation: A New Reproductive Health Option
Details
Company Overview
—
Mkt Cap
—
Revenue
—
Cash
Pipeline
Data sources: ClinicalTrials.gov (NIH) · OpenFDA (FDA) · ChEMBL (EMBL-EBI) · Open Targets (EBI/Sanger) · MedlinePlus (NIH) · PubMed (NIH) · SEC EDGAR (SEC)